Trials / Withdrawn
WithdrawnNCT04567589
A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada
A Cross-sectional Study Among Healthcare Professionals in Canada to Assess Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Allergan · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
This is a non-interventional, cross-sectional survey study to evaluate the effectiveness of the Additional Risk Minimization Measures for Fibristal among Healthcare Professionals (HCPs).
Detailed description
Data will be collected via web-based data capture by HCPs submitting surveys. The survey will be conducted in a single wave over 6 months. All data will be maintained in compliance with local regulations.
Conditions
Timeline
- Start date
- 2020-09-30
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2020-09-28
- Last updated
- 2020-10-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04567589. Inclusion in this directory is not an endorsement.